David M. Mott, 10% Owner at Mirum Pharmaceuticals, Inc. (MIRM), bought 4,186,243 shares at $15.00 ($6.8M) on 2019-07-22, disclosed to the SEC on 2019-07-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,736,243 | $0 | 0.0% |
| 2 | $15.00 | 450,000 | $6.8M | 100.0% |
| Total | $1.61 avg | 4,186,243 | $6.8M | 100% |
| Filing → |
| ARDX | BUY | 2025-06-11 | $738K | — | Filing → |
| ARDX | BUY | 2025-05-19 | $329K | — | Filing → |
| ARDX | BUY | 2025-05-05 | $3.2M | — | Filing → |